护理研究
護理研究
호리연구
Chinese Nursing Research
2015年
29期
3639-3641
,共3页
付本翠%伍金花%李慧%曹茂秋
付本翠%伍金花%李慧%曹茂鞦
부본취%오금화%리혜%조무추
乳腺癌%同伴教育%生存质量%化疗
乳腺癌%同伴教育%生存質量%化療
유선암%동반교육%생존질량%화료
breast cancer%peer education%quality of life%chemotherapy
[目的]探讨同伴教育对乳腺癌术后化疗病人生存质量的影响。[方法]将108例乳腺癌术后化疗病人随机分为两组各54例。对照组采用常规健康教育方式,观察组在对照组的基础上给予同伴教育。两组病人分别在入组时和干预3个月时进行生存质量测评(QLQ C30)。[结果]两组干预后生存质量评分的总体生存质量、5个功能维度(躯体功能、角色功能、认知功能、情绪功能、社会功能)和7个症状维度(疲劳、疼痛、恶心呕吐、失眠、食欲丧失、便秘、腹泻)评分比较差异有统计学意义(P <0.05)。[结论]同伴教育有助于提高乳腺癌化疗病人的生存质量。
[目的]探討同伴教育對乳腺癌術後化療病人生存質量的影響。[方法]將108例乳腺癌術後化療病人隨機分為兩組各54例。對照組採用常規健康教育方式,觀察組在對照組的基礎上給予同伴教育。兩組病人分彆在入組時和榦預3箇月時進行生存質量測評(QLQ C30)。[結果]兩組榦預後生存質量評分的總體生存質量、5箇功能維度(軀體功能、角色功能、認知功能、情緒功能、社會功能)和7箇癥狀維度(疲勞、疼痛、噁心嘔吐、失眠、食欲喪失、便祕、腹瀉)評分比較差異有統計學意義(P <0.05)。[結論]同伴教育有助于提高乳腺癌化療病人的生存質量。
[목적]탐토동반교육대유선암술후화료병인생존질량적영향。[방법]장108례유선암술후화료병인수궤분위량조각54례。대조조채용상규건강교육방식,관찰조재대조조적기출상급여동반교육。량조병인분별재입조시화간예3개월시진행생존질량측평(QLQ C30)。[결과]량조간예후생존질량평분적총체생존질량、5개공능유도(구체공능、각색공능、인지공능、정서공능、사회공능)화7개증상유도(피로、동통、악심구토、실면、식욕상실、편비、복사)평분비교차이유통계학의의(P <0.05)。[결론]동반교육유조우제고유선암화료병인적생존질량。
Objective:To probe into the influence of peer education on the quality of life of breast cancer patients receiving postoperative chemotherapy.Methods:A total of 108 breast cancer patients receiving postoperative chemotherapy were randomly divided into control group and experimental group,54 cases in each.The patients in control group received the routine health education,while the patients in observation group were given peer education on the basis of the routine health education.The patients in both groups were evaluated with QLQ C30 when entering into the groups and after three months of interventions.Results:There were statistically sig-nificant differences in overall quality of life,five functional dimensions (physical function,role function,cogni-tive function,emotional function,social function)and seven symptom dimensions (fatigue,pain,nausea,vomi-ting,insomnia,appetite loss,constipation,diarrhea)scores between both groups (P <0.05).Conclusion:Peer ed-ucation may improve the quality of life of breast cancer patients receiving postoperative chemotherapy.